Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM)
- Published on 03/29/2024
- Reading time: 4 min.
Frank D. Buono 1, Kaitlyn Larkin 2, William T. Zempsky 3,4, Lauretta E. Grau 5, Staci Martin 6
1
Yale School of Medicine
New Haven
Connecticut
USA
2
Northern Illinois University
DeKalb
Illinois
USA
3
Connecticut Children's Medical Center
Hartford
Connecticut
USA
4
University of Connecticut School of Medicine
Farmington
Connecticut
USA
5
Yale School of Public Health
New Haven
Connecticut
USA
6
National Cancer Institute
Bethesda
Maryland
USA
Abstract
Neurofibromatosis Type 1 (NF1) is an autosomal dominant genetic disorder that can cause an individual significant chronic pain (CP). CP affects quality of life and daily functioning, yet there are limited effective treatments for CP within NF1. The current study describes the impact of CP using the Neurofibromatosis Pain Module (NFPM). The NFPM is a self‐reported clinical assessment that evaluates the impact of CP across multiple domains (e.g., interference, severity, tolerance,...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Rare Diseases
Receive our newsletter to stay up to date with the latest news in Rare Diseases